Literature DB >> 26518296

Microglia in dementia with Lewy bodies.

Wolfgang J Streit1, Qing-Shan Xue2.   

Abstract

Microglial activation (neuroinflammation) is often cited as a pathogenic factor in the development of neurodegenerative diseases. However, there are significant caveats associated with the idea that inflammation directly causes either α-synuclein pathology or neurofibrillary degeneration (NFD). We have performed immunohistochemical studies on microglial cells in five cases of dementia with Lewy bodies (DLB), median age 87, and nine cases of non-demented (ND) controls, median age 74, using tissue samples from the temporal lobe and the superior frontal gyrus. Three different antibodies known to label microglia and macrophages were employed: iba1, anti-CD68, and anti-ferritin. All DLB cases showed both α-synuclein pathology (Lewy bodies and neurites) and NFD ranging from Braak stage II to IV. In contrast, all controls were devoid of α-synuclein pathology but did show NFD ranging from Braak stage I to III. Using iba1 labeling, our current results show a notable absence of activated microglia in all cases with the exception of two controls that showed small focal areas of microglial activation and macrophage formation. Both iba1 and ferritin antibodies revealed a mixture of ramified and dystrophic microglial cells throughout the regions examined, and there were no measurable differences in the prevalence of dystrophic microglial cells between DLB and controls. Double-labeling for α-synuclein and iba1-positive microglia showed that cortical Lewy bodies were surrounded by both ramified and dystrophic microglial cells. We found an increase in CD68 expression in DLB cases relative to controls. Since microglial dystrophy has been linked to NFD and since it did not appear to be worse in DLB cases over controls, our findings support the idea that the additional Lewy body pathology in DLB is not the result of intensified microglial dystrophy. CD68 is likely associated with lipofuscin deposits in microglial cells which may be increased in DLB cases because of impaired proteostasis. Overall, we conclude that neurodegenerative changes in DLB are unlikely to result directly from activated microglia but rather from dysfunctional ones.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lipofuscin; Microglial activation; Microglial dystrophy; Microglial senescence; Neurodegenerative disease; Neuroinflammation; α-Synuclein pathology

Mesh:

Substances:

Year:  2015        PMID: 26518296     DOI: 10.1016/j.bbi.2015.10.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  18 in total

1.  Microglial cell activation and senescence are characteristic of the pathology FXTAS.

Authors:  Verónica Martínez Cerdeño; Tiffany Hong; Sarwat Amina; Mirna Lechpammer; Jeanelle Ariza; Flora Tassone; Stephen C Noctor; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord       Date:  2018-12-10       Impact factor: 10.338

Review 2.  Advanced therapeutic strategies targeting microglia: beyond neuroinflammation.

Authors:  Min-Soo Kwon
Journal:  Arch Pharm Res       Date:  2022-09-27       Impact factor: 6.010

3.  Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Authors:  Daniel Erskine; Jinhui Ding; Alan J Thomas; Alice Kaganovich; Ahmad A Khundakar; Peter S Hanson; John-Paul Taylor; Ian G McKeith; Johannes Attems; Mark R Cookson; Christopher M Morris
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

4.  Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain.

Authors:  Ryan K Shahidehpour; Rebecca E Higdon; Nicole G Crawford; Janna H Neltner; Eseosa T Ighodaro; Ela Patel; Douglas Price; Peter T Nelson; Adam D Bachstetter
Journal:  Neurobiol Aging       Date:  2021-01-07       Impact factor: 4.673

Review 5.  Senescent Microglia: The Key to the Ageing Brain?

Authors:  Eleanor K Greenwood; David R Brown
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity.

Authors:  Matthew J Benskey; Rhyomi C Sellnow; Ivette M Sandoval; Caryl E Sortwell; Jack W Lipton; Fredric P Manfredsson
Journal:  Front Mol Neurosci       Date:  2018-02-13       Impact factor: 5.639

7.  Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.

Authors:  Zacharias Kohl; Johannes C M Schlachetzki; Judith Feldewerth; Philipp Hornauer; Martina Münch; Anthony Adame; Markus J Riemenschneider; Jürgen Winkler; Eliezer Masliah
Journal:  Neural Plast       Date:  2017-03-19       Impact factor: 3.599

8.  Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.

Authors:  Paula Garcia-Esparcia; Irene López-González; Oriol Grau-Rivera; María Francisca García-Garrido; Anusha Konetti; Franc Llorens; Saima Zafar; Margarita Carmona; José Antonio Del Rio; Inga Zerr; Ellen Gelpi; Isidro Ferrer
Journal:  Front Neurol       Date:  2017-03-13       Impact factor: 4.003

9.  Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease.

Authors:  Paul L Wood; Soumya Tippireddy; Joshua Feriante; Randall L Woltjer
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

10.  Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity.

Authors:  Dafina M Angelova; David R Brown
Journal:  Biomolecules       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.